Coagulation factor XIII polymorphisms and the risk of myocardial infarction and ischaemic stroke in young women

British Journal of Haematology

Volumn 116, Issue 2, 2002, Pages 376-382

  Teramura, Gayle ^a   Linenberger, Michael L ^a   Frank, Michele B ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Factor XIII; Myocardial infarction; Stroke; Thrombo embolic disease

Indexed keywords

BLOOD CLOTTING FACTOR 8; LEUCINE; PHENYLALANINE; TYROSINE; VALINE;

ADULT; ALLELE; ARTICLE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; DYSFIBRINOGENEMIA; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HEART INFARCTION; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; THROMBOSIS;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; FACTOR XIII; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MYOCARDIAL INFARCTION; ODDS RATIO; POLYMORPHISM, GENETIC; RISK;

EID: 0036177767     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2002.03265.x     Document Type: Article

References (27)

1. Genotype/phenotype correlations for coagulation factor XIII: Specific normal polymorphisms are associated with high or low factor XIII specific activity
2. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure
3. Val34Leu polymorphism of plasma factor XIII: Biochemistry and epidemiology in familial thrombophilia
4. Genetic polymorphisms and coronary artery disease in the South of France
5. The α2 gene coding sequence T807/A873 of the platelet collagen receptor integrin α2β1 might be a genetic risk factor for the development of stroke in younger patients
6. The association of the α-fibrinogen Thr312Ala polymorphism with post-stroke mortality in subjects with atrial fibrillation
7. α-fibrinogen Thr312Ala polymorphism and venous thromboembolism
8. The FXIII Val34Leu polymorphism in venous and arterial thromboembolism
9. The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction
10. Factor XIII Val34Leu and the risk of myocardial infarction
11. The Leu564 factor XIIIA variant results in significantly lower plasma factor XIII levels than the Pro564 variant
12. Association of a common polymorphism in the factor XIII gene with myocardial infarction
13. Prevalence of three common polymorphisms in the A-subunit gene of factor XIII in patients with coronary artery disease. Association with FXIII activity and antigen levels
14. Interaction between insulin resistance and factor XIII Val34Leu in patients with coronary artery disease
15. Fibrinogen Bellingham: A γ-chain R275C substitution and a β-promoter polymorphism in a thrombotic member of an asymptomatic family
16. Deficiency causing mutations and common polymorphisms in the factor XIII-A gene
17. Blood coagulation factor XIII: Structure and function
18. Genetic variants of platelet glycoprotein receptors and risk of stroke in young women
19. Polymorphisms of coagulation factor XIII subunit A and risk of non-fatal hemorrhagic stroke in young women
20. Platelet glycoprotein IIb polymorphism, traditional risk factors, and myocardial infarction in young women
21. Factor V Leiden (resistance to activated protein C) increases the risk of myocardial infarction in young women
22. A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women
23. Racial and genetic determinants of plasma factor XIII activity
24. Coexisting dysfibrinogenemia (γR275C) and factor V Leiden deficiency associated with thromboembolic disease (fibrinogen Cedar Rapids)
25. Examining thrombin hydrolysis of the factor XIII activation peptide segment leads to a proposal for explaining the cardioprotective effects observed with the factor XIII V34L mutation
26. Association of FXIII Val34Leu with decreased risk of myocardial infarction in Finnish males
27. Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-A